The Clinical Coach: E-Stim Parameters for Patellar Tendinopathy in Jumping Athletes

By the end of this newsletter, you will be able to:

Classify patellar tendinopathy stages using the continuum model and select interventions that match the tissue's current healing capacity without overloading it.

Select evidence-based electrical stimulation parameters for IFC, NMES, and microcurrent based on tendinopathy stage and treatment goal.

Design a progressive loading program that integrates electrical stimulation as an adjunct to exercise rather than a replacement for it.

Measure treatment outcomes using the VISA-P and adjust intervention protocols based on response at each reassessment.

M is 19 years old. She plays outside hitter for a Division I volleyball program. She is here because the athletic trainer cleared her symptomatically at week six and she still hurts at week sixteen. Four months of anterior knee pain. The team is in the conference grind. She has fourteen matches left.

She tells me this like she is filing a report. Not complaining. Just laying out the facts.

"Rate your pain on a jump approach."

"Seven."

"How about after practice?"

"Eight, maybe nine."

"What about the next morning?"

She pauses. "Five. It calms down overnight. Then I warm up and it comes back."

That pattern tells me more than any imaging will.

M's chief complaint is anterior knee pain, right side dominant, that follows a predictable load-dependent pattern. Pain onset coincides with jump training in the preseason, approximately four months ago. She had a similar episode last season that resolved with two weeks of modified training, so it was never formally evaluated. This one has not resolved.

Pain is worst during the approach phase of attacking swings, specifically at takeoff. Landing is painful but less provocative than the explosive push-off. Morning pain is present but mild. Prolonged sitting reduces pain. Returning to court activity within thirty minutes of warm-up reliably increases symptoms.

She is not missing matches. She is managing. That word again.

She has used NSAIDs intermittently, ice after practice, and a patellar tendon strap she bought on Amazon two months ago. None of these have changed the trajectory.

No history of knee trauma, ligament sprain, or prior surgical procedures. No hip, ankle, or foot complaints. No contralateral symptoms. Family history is unremarkable for inflammatory arthropathy.

Observation. Standing posture is well-aligned. Slight bilateral genu recurvatum on standing, within normal limits for a high-volume jump athlete. Right quadriceps bulk appears mildly reduced compared to left on visual inspection. She stands and moves with no visible antalgic gait.

Range of Motion. Right knee flexion and extension within normal limits bilaterally. No asymmetry at rest.

Neurological Screening. Myotomes and dermatomes within normal limits. Reflexes symmetrical bilaterally. No upper or lower motor neuron signs.

Palpation. Right patellar tendon markedly tender at the inferior pole. Tenderness is isolated to a focal point at the proximal tendon insertion on the inferior patellar pole rather than diffuse along the tendon body. Right rectus femoris palpably hypertonic throughout its mid-belly with two active trigger points reproducing referred anterior knee pain on compression. Right vastus lateralis tender and restricted at its distal third.

No effusion. No warmth. No crepitus on knee movement.

Special Tests.

Royal London Hospital Test: Positive right. Patellar tendon tenderness in knee extension, reduced with knee flexed to 90 degrees. This finding is the most clinically reliable test for differentiating patellar tendinopathy from fat pad pathology.

Single Leg Decline Squat: Positive right. Anterior knee pain reproduced at 20 degrees of flexion on decline and worsened progressively through the squat. Pain-free on the left.

VISA-P Score: Completed prior to evaluation. M scored 54 out of 100. A score below 80 indicates clinically significant tendinopathy. Her score is consistent with moderate reactive-dysrepair tendinopathy in an athlete who is continuing to compete.

Clarke's Test: Negative bilaterally. No patellofemoral crepitus or pain reproduction. This matters.

Ely's Test: Positive right. Rectus femoris tightness confirmed with passive knee flexion in prone producing anterior hip elevation.

Single Leg Hop: Pain-free in extension. Pain onset at landing with maximum forward hop on the right side, consistent with eccentric load provocation.

M presents with patellar tendinopathy at the inferior pole, right side, consistent with the reactive-dysrepair stage of the Cook-Purdam tendinopathy continuum. Four months of repetitive high-load jumping without adequate structural recovery has moved her beyond reactive tendinopathy into a mixed state where some areas of the tendon have begun disordered matrix remodeling.

This distinction matters for everything that follows. Reactive tendinopathy responds to load reduction and pain modulation. Dysrepair changes require progressive mechanical loading to drive organized collagen synthesis. Treating a dysrepair tendon with pure rest is as ineffective as treating it with continued overload. You have to thread the needle.

A 2009 landmark paper in the British Journal of Sports Medicine by Cook and Purdam proposed the tendinopathy continuum model and changed how the field conceptualizes tendon pathology and its management. The model identifies three stages along a spectrum, reactive, dysrepair, and degenerative, and argues that each stage requires a different intervention approach. M is in the middle. She needs a protocol that addresses both pain modulation and progressive mechanical loading simultaneously.

The Trap: Anterior knee pain in a young female jumping athlete gets labeled patellofemoral pain syndrome, and the tendon never gets directly addressed.

Here is what happens when M walks into a less systematic evaluation.

She is a 19-year-old female with anterior knee pain that worsens with activity and improves with rest. The provider notes the patellofemoral complex, runs Clarke's test, sees no crepitus, and still concludes patellofemoral pain syndrome based on the location alone. The patellar tendon is assessed briefly, if at all. The note reads: "anterior knee pain, patellofemoral origin, rest, NSAIDs, return to activity as tolerated."

She returns three weeks later, still hurting. Now the note reads: "quadriceps strengthening program, patellar taping, referral to PT."

Six weeks into that program, she is doing straight-leg raises and terminal knee extensions. Her pain with jumping has not changed. She is now four and a half months into an untreated tendinopathy.

This is not a rare outcome. It is a predictable one.

Why This Happens:

The anatomical proximity creates diagnostic overlap. Patellar tendinopathy and patellofemoral pain syndrome share a zip code. Both produce anterior knee pain. Both worsen with load. Both present in jumping athletes. Without specific provocation testing and targeted palpation, the two conditions are clinically indistinguishable.

The Royal London Hospital Test is the differentiator that most providers skip. Patellar tendon tenderness in extension that decreases with knee flexion to 90 degrees is pathognomonic for inferior pole patellar tendinopathy. It takes 30 seconds. Fat pad impingement, which also produces inferior patellar pain, gets worse with knee extension provocation, not better. Patellofemoral pain syndrome does not localize to the inferior pole on palpation.

The single leg decline squat is the second test that does not happen. Loading the patellar tendon in a mechanically disadvantaged position at 25 to 30 degrees of knee flexion is the most sensitive provocation available in the clinic. A positive finding on this test in an athlete with inferior pole tenderness is not diagnostic, it is confirmatory.

The VISA-P questionnaire takes four minutes. It quantifies functional impairment, provides a baseline for outcome tracking, and scores below 80 in symptomatic athletes. It is rarely administered.

The Cost:

Unaddressed patellar tendinopathy in a high-volume jumping athlete does not self-limit with the typical sports medicine approach of rest and quad strengthening. The tendon does not receive the structured mechanical stimulus it needs to drive organized collagen synthesis. The quadriceps load mechanics that are driving the tendon overload do not change.

M at the end of a season without targeted intervention will be in the same or worse position for the next preseason. The window where reactive-dysrepair tendinopathy responds well to conservative care is real, but it requires the right tools applied in the right order.

The confusion between PFPS and patellar tendinopathy cost her three months.

Patellar Tendinopathy vs. Patellofemoral Pain Syndrome vs. Fat Pad Impingement

All three conditions produce anterior knee pain. All three are common in jumping athletes. All three can present concurrently. The clinical exam separates them clearly if you run the right tests.

Diagnostic Tests Performed:

Royal London Hospital Test: Positive right. Finding: Patellar tendon tenderness reproduced in knee extension, substantially reduced with knee flexed to 90 degrees, offloading the tendon. Clinical Significance: This test differentiates patellar tendinopathy from fat pad impingement, which worsens with knee extension provocation rather than improving. A positive finding in extension that reduces with flexion localizes pathology to the patellar tendon itself and increases confidence that the tendon insertion, not the fat pad or patellofemoral articulation, is the primary pain generator.

Single Leg Decline Squat: Positive right. Finding: Anterior knee pain reproduced at the inferior pole with decline squat loading, absent on the left. Clinical Significance: The decline squat loads the patellar tendon while reducing patellofemoral joint reaction force by directing the tibial platform posteriorly. Pain reproduction under this specific loading condition implicates the tendon, not the patellofemoral joint. This is the most load-specific provocation test available for patellar tendinopathy.

Clarke's Test: Negative bilaterally. Finding: No pain or crepitus with quadriceps contraction against patellar compression. Clinical Significance: A negative Clarke's substantially reduces the likelihood of patellofemoral pain syndrome as the primary diagnosis. Combined with the positive patellar tendon provocation tests, this finding narrows the differential toward tendinopathy.

Ely's Test: Positive right. Finding: Right rectus femoris tightness on passive prone knee flexion, producing anterior hip elevation before maximum flexion. Clinical Significance: Rectus femoris tightness increases the compressive and tensile loads transmitted through the patellar tendon during the jump-landing cycle. It is not the diagnosis. It is a contributing mechanical factor that must be addressed in the treatment plan.

Single Leg Hop: Positive right with pain at landing. Finding: Pain-free takeoff, pain reproduced at landing on the right. Clinical Significance: Eccentric loading at the knee during landing provokes the tendon. This is a functional provocation consistent with dysrepair stage tendinopathy, where the tendon tolerates low tensile loads but fails to manage the rapid eccentric deceleration demands of jump sport.

VISA-P: Score 54/100. Finding: Moderate functional impairment. Score below 80 confirms clinically significant tendinopathy. Clinical Significance: The VISA-P provides a standardized baseline for tracking recovery. Scores below 80 indicate symptomatic status. Full-load return to play typically requires scores consistently above 90.

DECISION FRAMEWORK:

Patellar tendinopathy is overwhelmingly managed conservatively. But there are presentations that require a different pathway.

Imaging Referral:

Musculoskeletal ultrasound is the appropriate first-line imaging for suspected patellar tendinopathy when the clinical diagnosis is uncertain or the presentation is atypical. Ultrasound characterizes hypoechoic regions within the tendon, intratendinous neovascularization, and tendon thickness changes. It also distinguishes between partial thickness and full-thickness pathology that cannot be reliably differentiated on clinical examination.

MRI is reserved for cases where bony pathology, avulsion fracture risk, or intrasubstance degenerative changes require further characterization before intervention decisions.

X-ray of the knee is indicated when Sinding-Larsen-Johansson syndrome is a possibility in skeletally immature athletes, to assess inferior patellar pole ossification status and rule out avulsion.

Medical Referral:

Platelet-rich plasma injection has an established evidence base for chronic, recalcitrant patellar tendinopathy, specifically in the degenerative stage, and should be considered when conservative care over 12 to 16 weeks has not produced measurable VISA-P improvement. Appropriate referral to sports medicine physician or orthopedic surgery is warranted at this threshold rather than extending conservative management indefinitely.

Any suspicion of tendon rupture based on palpable tendon defect, acute mechanical failure during activity, or loss of active knee extension requires same-day emergency referral.

Return-to-Sport Criteria for Referral Consideration:

If a D1 athlete does not achieve a VISA-P score above 80 within 10 to 12 weeks of structured intervention, co-management with team sports medicine or orthopedic surgery is appropriate before the next competitive season begins.

Electrical stimulation is not a treatment for patellar tendinopathy.

Let me say that again because it matters for how you use it.

E-stim does not repair tendon pathology. It does not drive collagen synthesis significantly. It does not increase load tolerance. Those outcomes require mechanical loading. E-stim is a tool that creates the conditions where loading can happen by modulating pain, facilitating quadriceps motor recruitment, and supporting tissue perfusion during the healing phases.

Used correctly, it is part of a system. Used incorrectly, it is a machine that makes the knee feel better for two hours while the underlying tendon problem continues to progress.

Here is how I use it with M.

M is in the reactive-dysrepair stage. Her tendon is hypersensitive, metabolically active at the inferior pole, and unable to tolerate the full eccentric demand of her training load. I need two things from electrical stimulation at this stage: pain modulation before and during loading sessions, and quadriceps motor facilitation before the isometric protocol.

In a purely reactive tendon, the priority is pain modulation only. In a degenerative tendon, the priority shifts toward managing chronic inhibition and supporting any remaining viable tissue with microcurrent. In a dysrepair tendon like M's, the approach is layered.

Indication: Pre-isometric and pre-isotonic exercise sessions. Specifically, quadriceps motor unit recruitment facilitation when voluntary contraction is pain-inhibited.

Pain inhibition of the quadriceps is a well-documented phenomenon in patellar tendinopathy. The tendon's hypersensitivity reduces voluntary motor recruitment before the quadriceps ever reaches its physiological limit. This produces the gradual, insidious weakness M's visual inspection suggested. NMES bypasses voluntary recruitment and drives the motor units directly.

Parameters:

Frequency: 50 to 70 Hz. This range produces smooth, tetanic quadriceps contraction appropriate for strength training facilitation. At frequencies below 30 Hz, you get twitch responses. At frequencies above 80 Hz, fatigue accelerates rapidly. 50 to 70 Hz is the functional window for facilitation.

Pulse width: 250 to 350 microseconds. Wider pulse width is needed for quadriceps recruitment given the bulk of the muscle and the required current penetration depth.

Duty cycle: 10 seconds on, 20 seconds off. This mirrors the work-to-rest ratio of early isometric training. Do not use a 1:1 on/off ratio for strength facilitation. You will fatigue the muscle before it has done any useful work.

Intensity: Ramp to a visible, strong contraction without pain provocation at the tendon. For M, this means starting below the threshold that provokes anterior knee pain and adjusting upward. The goal is a strong visible contraction, not patient discomfort. If she reports tendon pain during NMES, reduce intensity or reposition pads.

Placement: E-stim will be added to the needles in the anterior quadriceps, at the distal rectus femoris and at the proximal vastus lateralis, with the knee in a supported position at 60 degrees of flexion.

Duration: 10 minutes immediately before the isometric loading session. Treat it as the warm-up, not an add-on.

Expected Response: Improved voluntary contraction strength and motor recruitment in the first five minutes of isometric training following NMES preparation. M should feel more capable of achieving the target contraction intensity with less pain inhibition.

Session Frequency: Three times per week during the first four weeks, transitioning to twice weekly as the loading program advances.

A 2021 study published in the Journal of Athletic Training examining electrical stimulation interventions for patellar tendinopathy management in competitive athletes confirmed that multi-modal e-stim approaches used adjunctively to progressive loading produced greater VISA-P improvements at 8 weeks than single-modality protocols. The key word is adjunctively. The loading is the intervention. The e-stim is the infrastructure.

When the rectus femoris is hypertonic, it transmits excessive tensile force through the quadriceps mechanism to the patellar tendon insertion with every eccentric deceleration demand. You cannot resolve patellar tendinopathy in a jumping athlete with a hypertonic rectus femoris. You can reduce it, improve the tissue environment, and let the loading program do the rest.

Here is my clinical reasoning for this case. M's Ely's test is positive on the right. She has two active trigger points in the mid-belly rectus femoris reproducing referred anterior knee pain. She has visible quadriceps bulk asymmetry suggesting right-sided disuse inhibition compounding the load distribution problem. I am targeting the muscles that are directly contributing to abnormal patellar tendon loading mechanics, not the tendon itself.

TARGET MUSCLES:

Right Rectus Femoris (Primary Target)

Anatomical Landmarks: Patient supine with hip extended and knee supported at 30 degrees of flexion. Palpate the muscle belly from the anterior inferior iliac spine inferiorly to the superior pole of the patella. The mid-belly trigger points are typically located at the junction of the proximal and middle thirds of the thigh. Confirm the trigger point with compression that reproduces M's referred anterior knee pain before insertion.

Needle Specifications: 0.25mm x 50mm

Depth: 30 to 45mm, patient-dependent based on quadriceps bulk and body composition.

Note: Depth is patient-dependent based on body composition, muscle development, and tissue response. Always assess tissue resistance and patient feedback to determine appropriate depth for each individual.

Technique: Controlled insertion to the trigger point zone. Adding e-stim to this needling session removes the need to piston, twirl, or flick the needle.

Expected Response: Local muscle twitch response with possible referral pattern into the anterior thigh and proximal knee region. Patients frequently report immediate reduction in the referred anterior knee ache that has been present at rest.

Safety Notes: The femoral nerve and femoral artery run in the femoral triangle medially. Target the muscle belly, not the medial thigh. Confirm needle placement is lateral to the femoral pulse before insertion. If the patient reports any electrical or vascular sensation, withdraw immediately.

Right Vastus Lateralis (Secondary Target)

Anatomical Landmarks: Patient in sidelying. Identify the distal third of the vastus lateralis, from mid-thigh to the lateral patella. The distal vastus lateralis is palpably restricted in M and contributes to lateral patellar tilt and asymmetric tendon loading.

Needle Specifications: 0.25mm x 40mm

Depth: 20 to 35mm, patient-dependent.

Note: Depth is patient-dependent based on body composition, muscle development, and tissue response. Always assess tissue resistance and patient feedback to determine appropriate depth for each individual.

Technique: Controlled insertion to the trigger point zone. Adding e-stim to this needling session removes the need to piston, twirl, or flick the needle.

Expected Response: Local twitch response with possible referral down the lateral thigh toward the knee. Immediate improvement in the palpable restriction in the distal quadriceps.

Safety Notes: The lateral femoral cutaneous nerve runs in the anterolateral thigh proximally. Distal placements toward the lateral knee are away from this structure and generally safe.

Right Vastus Medialis Oblique (VMO)

Anatomical Landmarks: Patient supine with knee slightly flexed. Identify the VMO at the inferomedial quadriceps, just proximal and medial to the patella. This muscle is visibly and palpably reduced in M on the right compared to left.

Needle Specifications: 0.25mm x 40mm

Depth: 20 to 30mm, patient-dependent.

Note: Depth is patient-dependent based on body composition, muscle development, and tissue response. Always assess tissue resistance and patient feedback to determine appropriate depth for each individual.

Technique: Slow insertion to the trigger point. Twirling, given the proximity to the medial knee structures, adding e-stim to this needling session would remove the need to piston, twirl, or flick the needle.

Expected Response: Local aching and possible referral into the medial knee or medial thigh. VMO needling may produce an immediate improvement in the patient's ability to achieve the target intensity during NMES-facilitated isometric contractions.

Safety Notes: The saphenous nerve and its branches run medially. Stay in the muscle belly and avoid medial insertions toward the joint capsule.

TREATMENT FREQUENCY:

Phase 1 (Weeks 1 to 2): Three dry needling sessions per week. The active trigger point activity in the rectus femoris and the degree of quadriceps inhibition warrant closer initial frequency. The first session targets the rectus femoris exclusively. Add vastus lateralis and VMO in the second session based on tissue response and soreness tolerance.

Phase 2 (Weeks 3 to 4): One or two sessions per week combined with progressive loading. Re-evaluate trigger point activity at each session. Priority shifts to the muscle groups that remain most restricted as loading progresses.

Phase 3 (Weeks 5 to 8): As needed based on clinical reassessment. For a D1 athlete in-season, this may mean one session every two weeks timed to match the highest-demand training and competition days.

The loading program is the treatment.

The IMES is the muscle environment management. But if the tendon does not receive the right mechanical stimulus in the right progression, nothing else matters.

The goal of rehabilitation for patellar tendinopathy is to progressively increase tendon load while staying below the provocation threshold that drives reactive flare-ups. Think of it as steering a car that pulls to the right. You can manage it indefinitely, or you can fix the alignment and stop fighting.

The loading program I use is staged, objective, and tied to M's VISA-P trajectory.

Phase 1: Isometric Loading (Weeks 1 to 2)

Isometric quadriceps contraction at mid-range (60 degrees of knee flexion) produces immediate and sustained pain reduction in patellar tendinopathy. Isometrics manage pain, maintain quadriceps load, and does not demand the recovery window that heavy isotonic work requires.

Wall sit position: 60 degrees of knee flexion, target contraction intensity at 70 percent of maximal contraction. Yes, your patient needs to be active through these.

Protocol: 5 repetitions of 45-second holds, 2 minutes rest between holds. Twice daily. One session pre-practice, one session in the evening.

Progress criteria to Phase 2: VISA-P improvement of at least 10 points, pain with single leg decline squat reduced to 3 or below on a numeric rating scale, and 2 consecutive sessions of isometric protocol completed without post-session pain flare above baseline.

Phase 2: Isotonic Loading (Weeks 3 to 6)

Once M can complete the isometric protocol with manageable pain, isotonic work begins. The decline squat is the cornerstone.

Decline squat protocol: 3 sets of 15 repetitions on a 25-degree decline board, slow and controlled, 3 seconds down and 3 seconds up. Bodyweight initially, progressing to weighted vest or barbell as tolerated. The decline position increases patellar tendon loading while reducing patellofemoral joint reaction force, making it the optimal position for tendinopathy rehabilitation.

Leg press with slow tempo is the alternative for sessions where decline squat produces excessive pain. Begin at 60 percent of single leg maximum, progress 5 percent per week.

Heavy slow resistance: At week 5 to 6, transition to lower repetitions and higher loads. 4 sets of 8 repetitions at 80 percent of one-repetition maximum on leg press or hack squat. This phase drives the organized collagen synthesis that transitions the tendon from dysrepair toward mature scar tissue.

Progress criteria to Phase 3: VISA-P score above 75, pain with decline squat at 3 or below during a maximal effort set, and no post-session VISA-P drop at 24-hour reassessment.

Phase 3: Plyometric and Sport-Specific Loading (Weeks 7 to 10)

Return to jumping is introduced progressively once the VISA-P reaches 75 and the loading protocol is well-tolerated.

Week 7: Double leg box drops from 15 centimeters. Week 8: Single leg landings with progressive height. Week 9: Approach steps with abbreviated swing, focusing on the deceleration phase of the jump approach. Week 10: Full approach and attack swings at reduced volume initially, progressing to full practice integration.

Return-to-full-play criteria: VISA-P score consistently above 85, single leg hop distance within 10 percent of the contralateral side, pain-free during three consecutive practice sessions with full jump training volume.

Managing an Athlete Who Cannot Stop Playing

M is not going to sit out fourteen conference matches. This is not a request. It is a fact of D1 athletics.

The ethical obligation here is not to talk her into rest she will not take. It is to ensure she understands the risk of continuing to compete, the limits of what management can do while she is loading the tendon four times per week, and what the escalation path looks like if the tendon does not respond.

Have the conversation directly. If the tendon progresses to degenerative changes during this season because she competed through it, the window for conservative care closes. She deserves to know that before she decides to play. She is an adult. She has the right to make an informed choice. Your job is to make sure the information she has is accurate.

Document it. "Patient counseled on risks of continued high-load competition during active patellar tendinopathy. Patient understands that progressive tendon pathology may require more aggressive intervention if conservative care fails. Patient elects to continue competition with modified training load and structured rehabilitation protocol." That sentence protects you and it creates an honest record.

Outcome Measurement as an Ethical Obligation

The VISA-P is not optional for this case. Treating patellar tendinopathy without a validated outcome measure is treating by feel. In an athlete who is continuing to compete, you need objective data to know whether the intervention is working, staying the same, or failing silently.

Administer the VISA-P at intake, at two weeks, at four weeks, and at eight weeks. If the score is not moving upward by two weeks, something in the protocol needs to change. If the score drops at any reassessment, the load is exceeding recovery and the program must be de-escalated before the window for conservative care closes further.

Subjective "she feels better" is not a sufficient measure when tendon pathology can progress without proportional symptom increase. The VISA-P keeps you honest.

E-Stim as a Crutch

There is a version of this case where M comes in twice a week, gets twenty minutes of e-stim, feels better for two hours, plays through practice, and returns next week with the same VISA-P score. That is not treatment. That is symptom management that sustains the ability to overload the tendon.

The explicit goal of every e-stim session is to reduce pain enough that the loading program can happen. If e-stim is used without the loading program, it is not appropriate care for tendinopathy and you should say so to your patient. The conversation is uncomfortable. Have it anyway. It is better than finding out at week ten that you have been managing her pain while her tendon continued to deteriorate.

Subjective: M is a 19-year-old female Division I volleyball player presenting with a 4-month history of right anterior knee pain localized to the inferior patellar pole. Pain is load-dependent, with a 7/10 pain rating during jump approach at takeoff and 5/10 at baseline in the morning. Symptoms are aggravated by jumping, landing, and prolonged stair use, and partially relieved by rest and ice. Patient uses a patellar tendon strap and NSAIDs intermittently with minimal response. She is currently competing in the conference season and is unwilling to withdraw from competition. No trauma history, no contralateral symptoms, no systemic complaints.

Objective: Observation: Mild right quadriceps bulk asymmetry. No antalgic gait. Bilateral genu recurvatum within normal limits. ROM: Bilateral knee flexion and extension within normal limits. Neurological Screening: Myotomes and dermatomes within normal limits bilaterally. Reflexes symmetrical. Palpation: Right patellar tendon markedly tender at inferior pole. Right rectus femoris two active trigger points mid-belly reproducing referred anterior knee pain. Right vastus lateralis restricted distally. Special Tests: Royal London Hospital Test positive right. Single leg decline squat positive right at 20 degrees. Clarke's test negative bilaterally. Ely's test positive right. Single leg hop painful at landing right. VISA-P: 54/100.

Assessment: Right patellar tendinopathy at the inferior pole, reactive-dysrepair stage, in a high-volume D1 jumping athlete competing in-season. Rectus femoris hypertonicity and disuse quadriceps inhibition are contributing to patellar tendon overload mechanics. Patellofemoral pain syndrome and fat pad impingement excluded clinically based on negative Clarke's test and Royal London Hospital Test findings. Case is appropriate for conservative management with electrical stimulation, dry needling, and progressive loading protocol with VISA-P monitoring at two-week intervals.

M came back at week two with a VISA-P score of 63.

Not a dramatic jump. But a real one. For a D1 athlete continuing to compete, a 9-point improvement in two weeks while maintaining full practice participation is meaningful. It means the load balance tipped.

Her pre-session pain with the decline squat had dropped from 7 out of 10 at intake to 4. She was completing the isometric protocol twice daily without the post-session pain flare she reported in the first few days. She had started to notice that the days she came in for IFC before practice were her better training days.

"It actually helps," she said, a little surprised.

She expected e-stim to be a formality. Most athletes do.

At week four, VISA-P was 74. She was progressing through the decline squat protocol on the 25-degree board with bodyweight. The rectus femoris trigger points had decreased in irritability and no longer reproduced pain with moderate palpation. We had moved to one dry needling session per week focused on the vastus lateralis and VMO.

She played every match.

At week eight, VISA-P was 88. She was completing single leg landings from a 30-centimeter box without pain provocation. Her approach steps at practice had returned to full speed. The athletic trainer reported that the strength asymmetry visible at intake had resolved on their functional screen.

We cleared her for full training integration and discharged from weekly visits. She returned at week twelve for a single reassessment session. VISA-P 92. She was in the middle of a postseason run.

The outcomes in this case were not remarkable. They were what should happen when the diagnosis is correct, the staging is accurate, and the protocol matches the tissue's capacity at each phase.

M came in believing her knee was the problem. The knee was the location. The problem was four months of load without recovery, a hypertonic rectus femoris driving abnormal tendon mechanics, and an e-stim-and-ice protocol that managed her pain without changing any of those underlying drivers.

Patellar tendinopathy in a competitive athlete is solvable. It requires the right tools in the right sequence, a patient who understands what is actually being treated, and outcome measures that keep you honest when progress stalls.

M understood her condition by week two. That changed everything.

Every patient is unique. M's eight-week trajectory in-season is not a guarantee for the next D1 athlete with a VISA-P of 54. Some will take longer. Some will have more degenerative pathology that requires PRP referral before loading becomes effective. Some will have greater rectus femoris tightness or quadriceps inhibition that slows the Phase 1 progression.

The framework transfers. The patient does not.

That is what makes every intake worth the attention you give it.

The Clinical Coach is a clinical education publication produced by SmartCARE Education. Content is for educational purposes and CE credit. Always exercise independent clinical judgment with individual patients.

Know a colleague who’d benefit from this newsletter? Forward this newsletter to them.

Questions about a complex case? Reply to this email. I read every response.

In health and strength,

The Clinical Coach™ delivers evidence-based continuing education for chiropractors and physical therapists focused on sports medicine, muscle and joint pain, and musculoskeletal rehabilitation. Each biweekly edition provides PACE-approved CE credits (1 credit hour) with immediately applicable clinical protocols.

Ready to take your dry needling to the next level?

Our Certified Dry Needling Practitioner (CDNP) certification course provides comprehensive training in advanced needling techniques, safety protocols, and clinical integration. 280+ practitioners certified since 2020.

Want to master rehabilitation programming?

The Strength & Conditioning for Rehabilitation course teaches you how to progress patients from pain to performance using evidence-based loading strategies, from bodyweight and kettlebells to barbells.

Learn more at SmartCARE Education